Moreover, in Cretan patients with non-alcoholic fatty liver disease (NAFLD), 6 g/day Spirulina (Greek production) supplementation for six months led to a significant reduction in the HOMA-IR index, a measure representing an enhancement in insulin sensitivity [70]. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.